Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 11:22 AM 2012  
VRX ELN ALKS PETS ACUR FLML 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for HSP

Hospira media headlines

    
    

Hospira Inc.

 Stock@American Stock Exchange 
United States
    
Use Hospira Inc. media headlines concurrently with your other holdings to enhance returns of your portfolios and to back test it against optimization strategy that fits your risk preferences.
    
    

    
  

Dr. Robin Smith Explaining NeoStem: A True Value Play

My goal moving forward in a very volatile and uncertain economy is to invest in stocks that I believe to be value investments. So far in 2012, I have written several articles expressing my beliefs that the absolute best value in the market is in the ...
  
  

Eloxatin - $1.2 billion

FiercePharma - May 16, 2012 Eloxatin managed to make the top 5 this time based on 2011, but 2012 may be another story. The drug goes off patent in August, and a slew of generics are already approved.
  
  

Hospira Recalls Overfilled Injection

As per reports, it has been revealed that Hospira Inc. (HSP) has recalled one lot of Hydromorphone Hydrochloride Injection, as it contained more than desired opioid.
  
  

Hospira Recalls One Lot Of Opioid Analgesic Injection

NASDAQ - May 15, 2012 (RTTNews.com) - Hospira Inc.(HSP) has initiated a nationwide voluntary recall of one lot of Hydromorphone Hydrochloride Injection 1 mg/ml, with the knowledge of the FDA, after it was found that the opioid analgesic injection contained more than the ...
  
  

Healthcare Business Recap: Possible Dividend Boosts, Hospira Slides

By Mark Lawson Shares of Ventrus Biosciences (NASDAQ:VTUS) pop, subsequent to the announcement that Phase III trials of its Diltiazem treatment for the relief of pain associated with anal fissures showed significant improvements over placebos.
  
  

Hospira recalls pain drug cartridges

MarketWatch - May 14, 2012 By Jon Kamp Hospira Inc. (NYSE:HSP) has recalled one lot of pre-filled cartridges containing the generic pain drug hydromorphone because the glass cartridges could contain too much medicine.
  
  

Hospira Recalls Pain Drug Cartridges On Over-Fill Concerns

By Jon Kamp Of DOW JONES NEWSWIRES Hospira Inc. (HSP) has recalled one lot of pre-filled cartridges containing the generic pain drug hydromorphone because the glass cartridges could contain too much medicine.
  
  

Hot Stocks of The Day (HSP, SIRI, GME, SPLK, MCP, SYMC)

Hospira Inc (NYSE:HSP) is down 0.87% to $33.05. The Company has recalled one lot of pre-filled cartridges containing the pain drug hydromorphone because the glass cartridges could contain too much medicine.
  
  

Hospira recalls opioid drug cartridges

MarketWatch - May 14, 2012 By Jon Kamp Hospira Inc. (NYSE:HSP) has recalled one lot of pre-filled cartridges containing the pain drug hydromorphone because the glass cartridges could contain too much medicine. Hospira Recalls One Lot Of Opioid Analgesic Injection - RTT News
  
  

Analyst Insights: Salesforce.com, Medivation, BioMarin, Hospira May 14th

By Derek Hoffman Salesforce.com (NYSE:CRM): Deutsche Bank said its channel checks indicate Salesforce.com underwent a large restructuring within its sales organization, which the firm believes could impact the company's Q1 results.
  
  

Hydromorphone Injection Recalled

Brevard Times - May 12, 2012 Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary user level recall of one lot of Hydromorphone Injection, USP, 1 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject?, NDC 0409-1283-31, due to two reported complaints of a single ... Hospira Announces A Nationwide Voluntary Recall Of One Lot Of Hydromorphone ... - Pharmaceutical Processing
  
  

Propofol drug shortages: The economic problem of a generic injectable

MedCity News - May 10, 2012 Propofol might best be known as the anesthetic Michael Jackson used inappropriately as a sleeping aid. Administered properly, the drug widely is used in hospitals to sedate patients.
  
  

Hospira Convenes Its 2012 Annual Meeting of Shareholders

Sacramento Bee - May 10, 2012 By Hospira, Inc. LAKE FOREST, Ill., May 9, 2012 -- /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today held its 2012 Annual Meeting of Shareholders in Arlington, Va.
  
  

Hospira to Present at Upcoming Investor Conferences

Sacramento Bee - May 9, 2012 By Hospira, Inc. LAKE FOREST, Ill., May 8, 2012 -- /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at the following upcoming ...
  
  

US Companies Reporting Negative EPS Surprises, May 1

The following US companies reported negative earnings surprises today. This list ranks percent surprises of actual earnings to earnings estimates.
  
    

Discuss Hospira media headlines

       
       

Hospira Revenue

    
    

Hospira Research Report

    
    

Hospira Total Debt

Based on latest financial disclosure Hospira Inc. has Total Debt of 1.78 B. This is 41.73% higher than that of Healthcare sector, and 38.07% higher than that of Drug Delivery industry, The Total Debt for all stocks is 62.39% higher than the company.
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.
    
Follow Hospira News with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Hospira to your reader
 
Get social with Hospira News
 Hospira News 
Share Toggle social options for Hospira News
    



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting